Recent News

• 04.04.2025 - Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
• 04.04.2025 - Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
• 03.07.2025 - Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
• 03.07.2025 - Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
• 02.26.2025 - Taysha Gene Therapies Fourth Quarter 2024 Financial Results Conference Call
• 02.26.2025 - Taysha Gene Therapies Fourth Quarter 2024 Financial Results Conference Call
• 02.26.2025 - Taysha Gene Therapies Reports Full-Year 2024 Financial Results and Provides Corporate Update
• 02.26.2025 - Taysha Gene Therapies Reports Full-Year 2024 Financial Results and Provides Corporate Update
• 02.19.2025 - Taysha Gene Therapies to Release Full-Year 2024 Financial Results and Host Conference Call and Webcast on February 26
• 02.19.2025 - Taysha Gene Therapies to Release Full-Year 2024 Financial Results and Host Conference Call and Webcast on February 26

Recent Filings

• 03.13.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.26.2025 - EX-99.1 EX-99.1
• 02.26.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.26.2025 - 8-K Current report
• 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.12.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.05.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 02.05.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors